Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Arcese

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Leukemia|January 18, 2019
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemiaV Alfonso, L Iaccarino, T Ottone, et al.
British Journal of Haematology|February 1, 1997
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)C Uderzo, M G Valsecchi, A Balduzzi, et al.
Blood|September 25, 1998
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow TransplantationM T Van Lint, C Uderzo, A Locasciulli, et al.
The Journal of Infection|December 22, 2015
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplantA Mengarelli, O Annibali, F Pimpinelli, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.
Bone Marrow Transplantation|September 27, 2016
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remissionF Saraceni, B Bruno, R M Lemoli, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemiaA P Iori, M Screnci, C Guglielmi, et al.
Bone Marrow Transplantation|February 27, 2007
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationM A Sanz, M Labopin, N-C Gorin, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Leukemia|January 18, 2019
Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemiaV Alfonso, L Iaccarino, T Ottone, et al.
British Journal of Haematology|February 1, 1997
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)C Uderzo, M G Valsecchi, A Balduzzi, et al.
Blood|September 25, 1998
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow TransplantationM T Van Lint, C Uderzo, A Locasciulli, et al.
The Journal of Infection|December 22, 2015
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplantA Mengarelli, O Annibali, F Pimpinelli, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.
Bone Marrow Transplantation|September 27, 2016
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remissionF Saraceni, B Bruno, R M Lemoli, et al.
Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemiaA P Iori, M Screnci, C Guglielmi, et al.
Bone Marrow Transplantation|February 27, 2007
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationM A Sanz, M Labopin, N-C Gorin, et al.
Pageof 16